This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
July 31, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced that it will report results for its fourth quarter and fiscal year 2012, ended
June 30, 2012 on
Thursday, September 6, 2012 after the market closes.
A conference call to review the results will begin at
2:00 p.m. PDT/
5:00 p.m. EDT and will be hosted by
Euan S. Thomson, Ph.D., president and chief executive officer and
Derek Bertocci, senior vice president and chief financial officer.
The conference call dial-in numbers are 1-800-295-4740 (
USA) or 1-617-614-3925 (International), Conference ID: 89497327. In addition, a dial-up replay of the conference call will be available beginning
September 6, 2012 at
5:00 p.m. PDT/
8:00 p.m. EDT and ending on
September 13, 2012. The replay telephone number is 1-888-286-8010 (
USA) or 1-617-801-6888 (International), Conference ID: 79000863.
A live webcast of the call will also be available from the Investor Relations section of the corporate website at
http://www.accuray.com/investors. A webcast replay can be accessed on the corporate website beginning
Thursday, September 6, 2012 at approximately
5:00 p.m. PDT/
8:00 p.m. EDT. The replay will remain available until Accuray announces its results for the first quarter of fiscal 2013, ending
September 30, 2012.
Accuray Incorporated (Nasdaq: ARAY), based in
Sunnyvale, Calif., is the premier radiation oncology company that develops, manufactures and sells personalized innovative treatment solutions that set the standard of care, with the aim of helping patients live longer, better lives. The Company's leading edge technologies – the CyberKnife and TomoTherapy Systems – are designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, and adaptive radiation therapy. To date, more than 635 systems have been installed in leading hospitals around the world. For more information, please visit